Icon Plc and Medpace are both CROs, but Icon focuses on large pharma with an aggressive M&A strategy, unlike Medpace's small biotech focus. Initially impressed by Icon's financials, we purchased ...

ICON plc, No. 25-cv-01807 ("PFRSD ... Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.'s Board of Directors, as well as $420 million from Teva ...

NEW YORK, NY / ACCESS Newswire / April 4, 2025 / If you suffered a loss on your ICON Public Limited Company (NASDAQ:ICLR) investment and want to learn about a potential recovery under the federal ...

CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (a)ICON was suffering from a material loss of business due to customer cost reduction ...

NEW YORK, March 24, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in ICON Public Limited Company ("ICON " or the "Company") (NASDAQ: ICLR) of a class action securities lawsuit.